China Resources Pharmaceutical Group Ltd. (640) Q4 2021 Earnings Report
DE:640 Q4 2021 EPS Results
- Actual EPS
- EUR 0.02
- Consensus EPS
- EUR 0.16
- Beat/Miss
- Missed by -EUR 0.14
- One Year Ago EPS
- EUR 0.01
DE:640 Q4 2021 Revenue Results
- Actual Revenue
- EUR 13.97B
- Expected Revenue
- EUR 85.98B
- Beat/Miss
- Missed by -EUR 72.01B
- YoY Revenue Growth
- +10.16%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 03/29/2022
- Time
- TBA
- Conference Call
- Tuesday, March 29, 2022
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:640 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 24, 2026 | 2026 (Q2) | 0.050.05 | 0.04 | 6.06% (+0.00) | |
| Mar 25, 2026 | 2025 (Q4) | 0.030.04 | 0.02 | 176.79% (+0.03) | |
| Aug 26, 2025 | 2025 (Q2) | 0.050.04 | 0.06 | -19.51% (-0.01) | |
| Mar 26, 2025 | 2024 (Q4) | 0.030.02 | 0.02 | -32.53% (-0.01) | |
| Oct 29, 2024 | 2024 (Q3) | ―- | 0.06 | ― | |
| Aug 29, 2024 | 2024 (Q2) | 0.060.06 | 0.06 | -8.07% (-0.00) | |
| Mar 26, 2024 | 2023 (Q4) | 0.030.02 | 0.02 | -7.26% (-0.00) | |
| Oct 30, 2023 | 2023 (Q3) | ―- | 0.06 | ― | |
| Aug 31, 2023 | 2023 (Q2) | ―0.06 | 0.06 | 6.44% (+0.00) | |
| Mar 30, 2023 | 2022 (Q4) | 0.020.02 | 0.02 | 4.68% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
